Article
The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations.
The FEBS journal - 1 Nov 2007
Wolf Jana, Dronov Serge, Tobin Frank, Goryanin Igor
Abstract excerpt
Epidermal growth factor receptor (EGFR)-mediated signal transduction is often hyperactivated in tumour cells and therefore considered a promising target for cancer therapy. A number of computational models have been developed which describe the pathway in great detail. These models are similar in their description of the activation events. The deactivation of the EGFR signalling seems to be cell type-specific and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
